Effectiveness and Safety of Suprachoroidal Injection of Triamcinolone in Patients with Resistant Macular Edema

Effectiveness and Safety of Suprachoroidal Injection of Triamcinolone in Patients with Resistant Macular Edema

Objective: To assess the effectiveness and safety of suprachoroidal injection of triamcinolone acetonide for treatment of resistant macular edema. Study Design: Non-randomized, pre-post experimental study. Place and Duration of Study: Armed Forces Institute of Ophthalmology, Rawalpindi Pakist...

Full description

Bibliographic Details
Main Authors:	Saquib Naeem, Noureen Malik, Jawwad Ahmad, Abdul Rauf, Teyyeb Azeem Janjua, Khalid Naimat
Format:	Article
Language:	English
Published:	Army Medical College Rawalpindi 2023-07-01
Series:	Pakistan Armed Forces Medical Journal
Subjects:	Central Macular thickness macular edema Suprachoroidal administration Triamcinolone acetate
Online Access:	https://www.pafmj.org/index.php/PAFMJ/article/view/9424

Similar Items

Concentrated triamcinolone acetonide suprachoroidally administered for the treatment of diabetic macular oedema
by: Petrović Nenad, et al.
Published: (2023-01-01)

Outcomes of Intravitreal Triamcinolone Acetonide Injection in Patients With Diabetic Macular Edema
by: Lokman Balyen, et al.
Published: (2018-01-01)

Peribulbar injection of triamcinolone acetonide as an outpatient clinic procedure in the management of mild to moderate macular edema
by: Mohammed S Ahmed
Published: (2021-01-01)

Delivery of Intraocular Triamcinolone Acetonide in the Treatment of Macular Edema
by: Brent Siesky, et al.
Published: (2012-03-01)

Combined Treatment of Persistent Diabetic Macular Edema with Aflibercept and Triamcinolone Acetonide in Pseudophakic Eyes
by: Nenad Petrovic, et al.
Published: (2023-05-01)

Effect of Intravitreal Triamcinolone on Different Optical Coherence Tomographic Patterns of Diabetic Macular Edema
by: Arif Koytak, et al.
Published: (2014-01-01)

Comparison of Intravitreal Triamcinolone Treatment and Intravitreal Triamcinolone with Grid Laser Treatment in Patients with Diffuse Diabetic Macular Edema
by: Berati Hasanreisoğlu, et al.
Published: (2012-06-01)

Efficacy of Formulated Posterior Subtenon Triamcinolone in Macular Edema secondary to Non–Ischemic Retinal Vein Occlusions
by: Ehab Tharwat, et al.
Published: (2022-06-01)

Formulated Posterior Subtenon Triamcinolone Versus Triamcinolone Alone in The Management of Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions
by: Ehab Tharwat
Published: (2023-01-01)

Combined Treatment with Bevacizumab and Triamcinolone Acetonide for Macular Edema Due to Retinal Vein Occlusion
by: Maja Vinković, et al.
Published: (2020-01-01)

Intravitreal Injections of 4 mg and 20 mg Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema: Comparison of Efficacy and Side Effects
by: Erkan Ünsal, et al.
Published: (2015-01-01)

Refractory post-surgical cystoid macular edema managed following suprachoroidal microcatheterization and delivery of triamcinolone
by: Marc D. de Smet, et al.
Published: (2023-09-01)

Effect of aflibercept combined with triamcinolone acetonide on aqueous humor growth factor and inflammatory mediators in diabetic macular edema
by: De-Shuang Li, et al.
Published: (2024-02-01)

Study of comparison of effect and complications of intravitreal triamcinolone injection of 1 mg, 2 mg and 4 mg in macular edema of vascular origin
by: Dr. Kajal Kataria, et al.
Published: (2023-12-01)

Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edema
by: Seung Hee Jeon, et al.
Published: (2024-01-01)

Optical coherence tomography biomarkers after intravitreal triamcinolone acetonide in patients with diabetic macular edema
by: Maria João Matias, et al.
Published: (2023-01-01)

Meta-analysis of the subconjunctival injection of triamcinolone acetonide in the treatment of macular edema secondary to non-infectious uveitis
by: Da-Hua Xu, et al.
Published: (2022-12-01)

Treatment of Failure of Macular Hole Closure due to Post-Vitrectomy Macular Edema Using Sub-Tenon Triamcinolone Acetonide Injection: A Case Report
by: Aiko Haraguchi, et al.
Published: (2024-04-01)

Retinal Microvascular Changes after Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema
by: Fusae Kato, et al.
Published: (2023-05-01)

Visual function and retinal morphological changes after single suprachoroidal delivery of fluocinolone acetonide (Iluvien®) implant in eyes with chronic diabetic macular edema
by: Ehab N. El Rayes, et al.
Published: (2023-03-01)

Long-term Results of Ranibizumab, Dexamethasone Implant, and Triamcinolone in Macular Edema due to Branch Retinal Vein Occlusion
by: Nevin Hande Dikel, et al.
Published: (2019-12-01)

Corticosteroid Treatment in Diabetic Macular Edema
by: Burcu Nurözler Tabakcı, et al.
Published: (2017-06-01)

COMPARISON OF INTRAVITREAL BEVACIZUMAB AND TRIAMCINOLONE ACETONIDE WITH INTRAVITREAL BEVACIZUMAB ALONE IN MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
by: Usman Attique, et al.
Published: (2021-03-01)

Risk factors for failing sub-Tenon’s triamcinolone acetonide for uveitic macular edema
by: Amit K. Reddy, et al.
Published: (2024-02-01)

A combination of suprachoroidal injection of triamcinolone using a custom-made needle and intravitreal Ziv-aflibercept every eight weeks to manage naïve/denovo central DME: a single-center retrospective case series
by: Ameen Marashi, et al.
Published: (2024-04-01)

The Frequency of Serous Macular Detachment in Diabetic Macular Edema
by: Onur Yaya, et al.
Published: (2015-05-01)

Efficacy of Aflibercept and Ranibizumab in the treatment of diabetic macular edema
by: Bing Wu, et al.
Published: (2023-08-01)

Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor
by: Fatma Savur, et al.
Published: (2022-12-01)

Retinal Thickness Deviation: A New OCT Parameter for Assessing Diabetic Macular Edema
by: Paola Marolo, et al.
Published: (2023-06-01)

Evaluation of the Relationship Between Diabetic Macular Edema and Renal Function in a Latino Population
by: José M. Torres-Arellano, et al.
Published: (2023-08-01)

Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Refractory Diffuse Diabetic Macular Edema
by: Mohammad-Hossein Dehghan, et al.
Published: (2010-01-01)

Defining Cystoid Macular Degeneration in Diabetic Macular Edema: An OCT-Based Single-center Study
by: Gökçen Yalçın, et al.
Published: (2019-12-01)

Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
by: Wungrak Choi, et al.
Published: (2020-11-01)

Ziv-aflibercept in Diabetic Macular Edema: Relation of Subfoveal Choroidal Thickness with Visual and Anatomical Outcomes
by: Siamak Moradian, et al.
Published: (2023-04-01)

Correlation between different retinal layers with visual acuity in diabetic retinopathy patients with clinically significant macular edema
by: Shama Parveen, et al.
Published: (2023-01-01)

Anti-Vascular Endothelial Growth Factor Therapy with or Without Initial Steroid Therapy for Macular Edema in Branch Retinal Vein Occlusion
by: Noma H, et al.
Published: (2023-08-01)

Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema
by: Santosh K Mahapatra, et al.
Published: (2024-01-01)

Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in diabetic macular edema in clinical practice
by: Rajya L Gurung, et al.
Published: (2023-04-01)

Effect of Conbercept on serum lncRNA MALAT1 levels and central macular thickness in patients with diabetic macular edema
by: Wen-Jun Gou, et al.
Published: (2023-01-01)

Is a Decreased Nitric Oxide Concentration after Triamcinolone Acetonide Intravitreal Injection One of the Reasons for Intraocular Pressure Rise?
by: Nenad Petrović, et al.
Published: (2022-01-01)